Adenovirus-mediated suppression of hypothalamic glucokinase affects feeding behavior.
Romina María UrangaCarola MillánMaría José BarahonaAntonia RecabalMagdiel SalgadoFernando MartinezPatricio OrdenesRoberto Elizondo-VegaFernando SepúlvedaElena UribeMaría de Los Ángeles García-RoblesPublished in: Scientific reports (2017)
Glucokinase (GK), the hexokinase involved in glucosensing in pancreatic β-cells, is also expressed in arcuate nucleus (AN) neurons and hypothalamic tanycytes, the cells that surround the basal third ventricle (3V). Several lines of evidence suggest that tanycytes may be involved in the regulation of energy homeostasis. Tanycytes have extended cell processes that contact the feeding-regulating neurons in the AN, particularly, agouti-related protein (AgRP), neuropeptide Y (NPY), cocaine- and amphetamine-regulated transcript (CART) and proopiomelanocortin (POMC) neurons. In this study, we developed an adenovirus expressing GK shRNA to inhibit GK expression in vivo. When injected into the 3V of rats, this adenovirus preferentially transduced tanycytes. qRT-PCR and Western blot assays confirmed GK mRNA and protein levels were lower in GK knockdown animals compared to the controls. In response to an intracerebroventricular glucose injection, the mRNA levels of anorexigenic POMC and CART and orexigenic AgRP and NPY neuropeptides were altered in GK knockdown animals. Similarly, food intake, meal duration, frequency of eating events and the cumulative eating time were increased, whereas the intervals between meals were decreased in GK knockdown rats, suggesting a decrease in satiety. Thus, GK expression in the ventricular cells appears to play an important role in feeding behavior.
Keyphrases
- induced apoptosis
- cell cycle arrest
- poor prognosis
- binding protein
- spinal cord
- physical activity
- weight loss
- stem cells
- cell death
- type diabetes
- cell therapy
- endoplasmic reticulum stress
- blood pressure
- pulmonary hypertension
- mitral valve
- mesenchymal stem cells
- high throughput
- gene therapy
- rna seq
- atrial fibrillation
- prefrontal cortex